Vanguard Global Advisers
ANVS icon

Vanguard Global Advisers’s Annovis Bio ANVS Stock Holding History

Vanguard Global Advisers’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.8K Hold
11,190
– – ﹤0.01% 3316
2026
Q1 		$25K Buy
+11,190
New +$30.7K ﹤0.01% 3247

Other funds holding ANVS

EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Vanguard Global Advisers's ANVS Position: Q2 2026 in Review

Vanguard Global Advisers held its Annovis Bio (ANVS) position steady in Q2 2026 at 11,190 shares worth $20.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3316.

Vanguard Global Advisers first reported a position in ANVS in Q1 2026 and has held it in 2 quarters since. The position peaked at $25K in Q1 2026. 57 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

  • Vanguard Global Advisers held 11,190 shares of Annovis Bio worth $20.8K as of Q2 2026.
  • Vanguard Global Advisers left its Annovis Bio share count unchanged in Q2 2026.
  • Annovis Bio made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #3316 holding.
  • Vanguard Global Advisers first reported a position in Annovis Bio in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's Annovis Bio position peaked at $25K in Q1 2026.
  • 57 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.